The IU Simon Cancer Center’s annual Cancer Research Day is expanding to two days, May 2-3, for the first time in 2018.
The tw0-day format will provide presenters more time with their posters for exposure and exploration by their fellow cancer researchers. In all, more than 120 posters will be on display, graduate students and post-docs will make presentations, guest speakers will participatie in a symposium, and David Gerber, M.D., of UT Southwestern will deliver the keynote address during this year’s event. (See the agenda below.)
Students, fellows and faculty conducting cancer research at IUPUI, Indiana University-Bloomington, Purdue University, and the Harper Cancer Research Institute, a collaboration between the IU School of Medicine and the University of Notre Dame, will present their current cancer research efforts at Cancer Research Day. Cash awards for best posters by graduate students, post-doctoral/medical fellows, research technicians and clinical nurses in all research categories will be selected by a review board.
Cancer Research Day is an annual event that aims to increase understanding and awareness of IU Simon Cancer Center research endeavors and encourage collaboration with other cancer research institutions in Indiana.
Questions? Send an e-mail to email@example.com.
Wednesday, May 2 (all events take place in the IUPUI Campus Center, 420 University Blvd.)
Poster presentations (Posters can be put on display from 2:30 p.m. to 4 p.m.), Room 450
If you are unable to have your poster on display on May 2, you must have it on display by 10:30 a.m. May 3. (Poster set-up on May 3 is 7:30-10:30 a.m.)
Reception, Room 450
The reception is for presenters, judges and other invited guests. During the reception, selected reviewers will read and grade posters for awards that will be presented May 3. If your poster is on display, you must be present.
Thursday, May 3 (all events take place in the IUPUI Campus Center, 420 University Blvd.)
Symposium, Theater Level (lower level)
Pier Paolo Scaglioni, M.D., of University of Cincinnati Health Barrett Cancer Center
“Fatty Acid Metabolism is a Therapeutic Target in Mutant KRAS Lung Cancer”
Mark Kelley, Ph.D., of Indiana University
“Exploiting the Ref-1/APE1 Signaling Node for Targeted Cancer Therapy: From Bench to First-in-Class Clinical Trials”
Roberto Pili, M.D., of Indiana University
“Integrating Epigenetics, Immunomodulation, and Dietary Interventions in Cancer Patients”
Milan Radovich, Ph.D., of Indiana University
“Precision Medicine in a Rare Cancer: Genomics and Clinical Vulnerabilities in Thymic Epithelial Tumors”
Graduate student presentations, Theater Level (lower level)
Selected abstracts by Saeed Salehin Akhand, Beth Facchine, Joseph Rupert, and Xingyue Zong.
11 a.m.-1:30 p.m.
Lunch/Poster abstract presentations, Room 450
11 a.m.-12:30 p.m., Selected reviewers will read and grade posters for awards. Presenters must be at their posters at this time.
Post-doc presentations, Theatre Level (lower level)
Selected abstracts by Nur Damayanti, Yujing Li, Naveen Singh, and Navnath Gavande.
Keynote speaker, Theatre Level (lower level)
David Gerber, M.D., of UT Southwestern
David Gerber, M.D., presents “From Inception to Exceptional: Experimental Therapeutics at the Simmons Comprehensive Cancer Center.” Dr. Gerber is co-leader of the Experimental Therapeutics Program and associate director for clinical research at the Harold C. Simmons Comprehensive Cancer Center at the University of Texas Southwestern Medical Center, and he is professor of internal medicine in the Division of Hematology and Oncology and professor of clinical sciences at the University of Texas Southwestern Medical Center.
Awards ceremony, Theater Level (lower level)
Closing remarks, Theater Level (lower level)
page updated April 30